AMBOSS completes acquisition of NEJM Knowledge+ from NEJM Group to revolutionize medical education
Acquiring Company
AMBOSS
Acquired Company
NEJM Knowledge+
BostonInformation TechnologyHealth CareEducationMedicalBiotechnologyHealth CareEducationNon ProfitDescription
AMBOSS, the leading clinical resource for residents, proudly announces its recent acquisition of NEJM Knowledge+ from NEJM Group, setting a new standard in medical education and clinical practice. This acquisition integrates NEJM Knowledge+ with AMBOSS's clinical decision support tool, offering an unparalleled resource for modern healthcare professionals to build their knowledge base and drive clinical decision-making throughout their careers.
Quick answer
AMBOSS is acquiring NEJM Knowledge+, announced April 25, 2024.
- How much did AMBOSS pay for NEJM Knowledge+?
- The deal value was not disclosed.
- What does AMBOSS do?
- AMBOSS is a medical technology company with offices in New York, Berlin, Cologne and Cagliari.
- Where are AMBOSS and NEJM Knowledge+ based?
- NEJM Knowledge+ is based in Boston, Massachusetts, United States.
- Who are the decision-makers at AMBOSS?
- Fundz holds 1 contact at AMBOSS. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Education and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Dover Health expands into Illinois through acquisition of Centered Care Hospice and Palliative Care, and Cornerstone Home Health (June 6, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
Who to call at AMBOSS, and when
When AMBOSS changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AMBOSS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AMBOSS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AMBOSS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AMBOSS makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired NEJM Knowledge+?
NEJM Knowledge+ was acquired by AMBOSS. The deal was reported on April 25, 2024. AMBOSS is a medical technology company with offices in New York, Berlin, Cologne and Cagliari. Its knowledge platform has fundamentally changed the way medical know-how is acquired and utilized at the point of care. AMBOSS is privately held and operates in Information Technology.
When did AMBOSS acquire NEJM Knowledge+?
AMBOSS's acquisition of NEJM Knowledge+ was reported on April 25, 2024. AMBOSS, the leading clinical resource for residents, proudly announces its recent acquisition of NEJM Knowledge+ from NEJM Group, setting a new standard in medical education and clinical practice. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does NEJM Knowledge+ do?
NEJM Knowledge+ is a learning and assessment tool for clinicians created by NEJM Group, publishers of the New England Journal of Medicine and other prominent medical resources for physicians and other health professionals. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.